Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

European Organisation for Research and Treatment of Cancer - EORTC

ClinicalTrials.gov Identifier:

NCT00005061

First received: April 6, 2000

Last updated: July 17, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2001 (Final data collection date for primary outcome measure)